Profile of delamanid for the treatment of multidrug-resistant tuberculosis

New approaches to the treatment of multidrug-resistant and extensively drug-resistant tuberculosis (TB) are badly needed. Not only is the success rate of current treatment regimens suboptimal but existing regimens require multiple drugs and lengthy courses and may lead to significant toxicities. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Szumowski, John D, Lynch, John B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319680/
https://www.ncbi.nlm.nih.gov/pubmed/25678771
http://dx.doi.org/10.2147/DDDT.S60923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319680/
https://www.ncbi.nlm.nih.gov/pubmed/25678771
http://dx.doi.org/10.2147/DDDT.S60923

Ejemplares similares